61.4 F
New York
Wednesday, September 23, 2020

Ovid Therapeutics Inc. (NASDAQ:OVID) is Holding Steady

Must read

The Unprecedented Rise of BioNTech SE (NASDAQ:BNTX)

BioNTech SE (BNTX) shares are trading at lower $66.12 and the avg recommendation for the stock is Moderate Buy. while the current analyst price...

Livent Corporation (NYSE:LTHM) is Holding Steady

Livent Corporation (LTHM) shares are trading at lower $8.38 and the avg recommendation for the stock is Moderate Buy. while the current analyst price...

The Forecast Just Changed on Ruth’s Hospitality Group Inc. (NASDAQ:RUTH)

Ruth's Hospitality Group Inc. (RUTH) shares are trading at lower $10.60 and the avg recommendation for the stock is Moderate Buy. while the current...

Avadel Pharmaceuticals plc (NASDAQ:AVDL) Recent Earnings Shows Major Promise

Avadel Pharmaceuticals plc (AVDL) shares are trading at higher $6.08 and the avg recommendation for the stock is Strong Buy. To add more color...

The Ovid Therapeutics Inc. (OVID) shares are trading at lower $7.00 and the avg recommendation for the stock is Strong Buy. while the current analyst price target stands at $13.00.

To add more color to this target, the company’s high over the last year is $9.40 and the low is $1.74. Over the last 52 weeks, OVID is down -25.53% while the S&P 500 is down -0.87%. The catalyst for this interesting swing was the company’s recent earnings report.

A Notable Earnings Report

In the last quarter, OVID reported a profit of $0.26 million. Ovid Therapeutics Inc. also saw revenues increase to $20.29 million. In addition, OVID has free cash flow of -$18.43 million as of 03-2020. The company’s EBITDA came in at -$20.23 million which compares well with its peers.

OVID Return on Equity (ROE) is -135.40%, and its Return on Assets is -112.00%. All told, it is clear that, OVID needs to be on your watchlist.

Find out when OVID reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.

Of course, we must look beyond the financials and question how well those numbers represent the sustainable earnings power of the business. Investors need to know how sustainable this current run. OVID has a short ratio of 2.46 and outstanding shares of 54.72M.

Company Outlook

OVID has seen increased volume after this news and investors are putting their support behind the value proposition. Furthermore, 10-day volume stands at 0.75 million and more growth is possible in the weeks ahead. Traders will also note the company’s earnings per share came in at -1.48. Ovid Therapeutics Inc. OVID also noted assets of $61.72 million at the end of the last quarter. Investors should also keep an eye on sector updates as OVID has historically followed its peers on positive news.

All told, Ovid Therapeutics Inc. OVID has strung together solid data and demonstrated underlying fundamentals. At its current valuation, OVID represents an interesting risk/reward case. Traders should stay tuned to see if this recent report will push the stock to test recent resistance levels.

Ovid Therapeutics Inc. OVID is now commanding a market cap of 400.68M and a float of 32.76M. OVID is increasing its credibility in this sector and that could lead to more upside down the line. Sign-up for continuing coverage on shares of OVID stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!

Disclosure: we hold no position in OVID, either long or short, and we have not been compensated for this article.

Latest article

Urban Outfitters Inc. (NASDAQ:URBN) on the Path to Ruin

Urban Outfitters Inc. (URBN) shares are trading at lower $21.02 and the avg recommendation for the stock is Moderate Buy. while the current analyst...

Is Now the Time to Invest in Dollar Tree Inc. (NASDAQ:DLTR)?

Dollar Tree Inc. (DLTR) shares are trading at lower $85.97 and the avg recommendation for the stock is Moderate Buy. while the current analyst...

Teradyne Inc. (NASDAQ:TER) Stock is Soaring, Here is Why

Teradyne Inc. (TER) shares are trading at higher $76.92 and the avg recommendation for the stock is Moderate Buy. while the current analyst price...

Huntsman Corporation (NYSE:HUN) is Holding Steady

Huntsman Corporation (HUN) shares are trading at lower $22.07 and the avg recommendation for the stock is Moderate Buy. while the current analyst price...

Investor Confidence is Rising for Electronic Arts Inc. (NASDAQ:EA)

Electronic Arts Inc. (EA) shares are trading at higher $128.29 and the avg recommendation for the stock is Moderate Buy. while the current analyst...